Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 04, 2026 08:00 ET | Source: ARS Pharmaceuticals, Inc.

Drew Brees Collaborates with ARS Pharmaceuticals to Raise Awareness About Living Life with Severe Allergies

Former NFL quarterback and 2026 Hall of Fame inductee highlights daily life for people living with severe food allergies and role preparedness plays in living fully Collaboration focuses on...
June 03, 2026 08:00 ET | Source: Noah Medical

Noah Medical Appoints Dr. Krish Bhadra as Chief Pulmonary Advisor

Dr. Krish Bhadra joins medical robotics company Noah Medical as Chief Pulmonary Advisor.
June 03, 2026 08:00 ET | Source: Terra Balcanica Resources Corp.

Terra Balcanica Obtains Exploration Licence in Bosnia-Herzegovina

Vancouver, British Columbia, June 03, 2026 (GLOBE NEWSWIRE) -- Terra Balcanica Resources Corp. (“Terra” or the “Company”) (CSE:TERA; FRA:UB1; OTCQB:TEBAF) is pleased to announce that it has secured...
June 02, 2026 08:00 ET | Source: Centrical

Centrical Raises $39M to Transform Frontline Performance for the AI Era Workforce

The investment will fund Centrical’s global expansion and the development of AI tools to manage frontline performance for human and digital workers.
June 01, 2026 08:18 ET | Source: Vaxart, Inc.

Vaxart Files Definitive Proxy Statement and Mails Letter to Shareholders

Emphasizes Importance of Experienced Biotech Leadership as Vaxart Advances Clinical and Strategic Priorities with Multiple Value-Creating Milestones Ahead Highlights Significant Risk of Replacing...
June 01, 2026 08:00 ET | Source: Nasus Pharma, Ltd.

Nasus Pharma to Host Virtual KOL Event on June 10, 2026 to Discuss NS002 for the Treatment of Anaphylaxis

TEL AVIV, Israel, June 01, 2026 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) (“Nasus Pharma” or the “Company”), a clinical-stage pharmaceutical company focused on the development of innovative...
May 29, 2026 19:00 ET | Source: Kirby McInerney LLP

EMBC INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Embecta Corp.

NEW YORK, May 29, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP continues its investigation on behalf of Embecta Corp. (“Embecta” or the “Company”) (NASDAQ:EMBC) investors concerning...
May 29, 2026 12:37 ET | Source: Brandon Hall Group

Motivosity Earns Brandon Hall Group™ Smartchoice® Preferred Solution Provider Certification

Boca Raton, FL, May 29, 2026 (GLOBE NEWSWIRE) -- Motivosity, a leading employee recognition and rewards platform focused on building connected workplace cultures, today announced it has been...
May 29, 2026 12:30 ET | Source: MannKind

MannKind Announces FDA Approval of Afrezza®, the First and Only Inhaled Mealtime Insulin for Use in Children and Adolescents Aged 6 and Older Living with Diabetes

MannKind Announces FDA Approval of Afrezza® the 1st & Only Inhaled Mealtime Insulin for Use in Children & Adolescents Aged 6 and Older Living with Diabetes
May 28, 2026 17:11 ET | Source: Bragar Eagel & Squire

Bragar Eagel & Squire, P.C. is Investigating Embecta Corp. on Behalf of Embecta Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Embecta (EMBC) To Contact Him Directly To Discuss Their Options If you purchased or...